The 2025 Centers for Disease Control and Prevention Nonoccupational HIV Postexposure Prophylaxis Guidelines: Updated Regimens and Remaining Questions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41094598.
- Also identified by DOI 10.1093/cid/ciaf567 and PMC identifier 12643382.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The United States Centers for Disease Control and Prevention recently released updated guidance on nonoccupational human immunodeficiency virus postexposure prophylaxis. The guidelines introduce coformulated antiretrovirals as a preferred regimen, which will likely positively impact prescribing practices and adherence. However, other barriers to access and uptake remain a challenge.
Medical subject headings
- HIV Infections
- Post-Exposure Prophylaxis
- Anti-HIV Agents
- Practice Guidelines as Topic